Clinical Trial Update: Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression [Phase 3]

View source ↗

Summary

Phase 3, controlled study evaluating quetiapine fumarate in bipolar depression has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED